Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
What Does Spx Level Tell You About Market distills the level into actionable insights about market breadth and momentum.
28,520 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The NYC Council greenlights a 72-story Brooklyn tower with 1,263 units, a quarter permanently affordable. Constructio...
Geopolitical tensions in the Middle East are lifting costs and risk for U.S. ports. Analysts warn that bunker fuel pr...
FCX and NEM beat quarterly estimates, but 2026 headwinds and project timing are shaping whether one stock outperforms...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
Vail Resorts is signaling a strategic pivot away from the iconic $1,000 Epic Pass as season results lag and weather c...
In a markets backdrop marked by higher rates and sector stresses, SRET continues to pay monthly distributions, unders...
If Spirit faces liquidation, the fleet faces a multi-step journey from repossession to resale. Here's a concise brief...
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...
A papal address warns of a spiraling risk as AI arms development accelerates, prompting markets to reassess risk, ass...
A fresh study presented at Gartner's Data & Analytics Summit argues that attaching semantic meaning to data could dra...
Retirees should anchor planning on cash flow rather than asset size. Here is how the math stacks up in today's market...